Stock Screener
Stock Research
Market Indexes
Precious Metals
Energy
Commodities
Interest Rates
Economy
Global Metrics

Corcept Therapeutics Change in Inventories 2010-2025 | CORT

Corcept Therapeutics annual/quarterly change in inventories history and growth rate from 2010 to 2025. Change in inventories can be defined as the increase or decrease in a company's inventories for the period.
  • Corcept Therapeutics change in inventories for the quarter ending June 30, 2025 was $-0.004B, a 476.07% increase year-over-year.
  • Corcept Therapeutics change in inventories for the twelve months ending June 30, 2025 was $-0.003B, a 209.73% decline year-over-year.
  • Corcept Therapeutics annual change in inventories for 2024 was $0B, a 75.89% decline from 2023.
  • Corcept Therapeutics annual change in inventories for 2023 was $0.001B, a 5.5% increase from 2022.
  • Corcept Therapeutics annual change in inventories for 2022 was $0.001B, a 65.19% decline from 2021.
  
Corcept Therapeutics Annual Change in Inventories
(Millions of US $)
2024 $0
2023 $1
2022 $1
2021 $3
2020 $-4
2019 $-1
2018 $-8
2017 $-2
2016 $-1
2015 $1
2014 $0
2013 $-1
2012 $-5
2011 $N/A
2010 $N/A
2009 $N/A
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $7.347B $0.675B
Corcept is focused on the discovery, development and commercialization of drugs for the treatment of severe metabolic, psychiatric and oncology disorders which are associated with the activity of the hormone cortisol, also known as the stress hormone. Corcept's only marketed drug, Korlym (mifepristone), is approved for the once-daily oral treatment of hyperglycemia secondary to hypercortisolism in adult patients with endogenous Cushing's syndrome, suffering from type II diabetes or glucose intolerance and who have failed surgery or are not suitable for surgery.
Stock Name Country Market Cap PE Ratio
Chugai Pharmaceutical (CHGCY) Japan $72.041B 27.71
Zoetis (ZTS) United States $69.314B 25.14
Takeda Pharmaceutical (TAK) Japan $47.697B 9.73
Daiichi Sankyo, - (DSNKY) Japan $45.256B 23.19
BeOne Medicines - (ONC) Switzerland $33.543B 0.00
Sandoz Group AG (SDZNY) Switzerland $27.672B 0.00
Summit Therapeutics (SMMT) United States $17.605B 0.00
Merck (MKKGY) Germany $16.427B 10.68
Shionogi (SGIOY) Japan $14.649B 14.68
Neurocrine Biosciences (NBIX) United States $13.846B 41.30
United Therapeutics (UTHR) United States $13.747B 11.90
IPSEN (IPSEY) France $11.409B 0.00
Orion OYJ (ORINY) Finland $11.203B 27.00
Madrigal Pharmaceuticals (MDGL) United States $9.722B 0.00
Eisai (ESAIY) $8.913B 10.05
Stevanato Group S.p.A (STVN) Italy $6.968B 41.09
Grifols, S.A (GRFS) Spain $6.855B 0.00
Ionis Pharmaceuticals (IONS) United States $6.796B 0.00
Ono Pharmaceutical (OPHLF) Japan $5.740B 19.71
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $5.436B 0.00
Soleno Therapeutics (SLNO) United States $3.596B 0.00
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $3.003B 14.27
Crinetics Pharmaceuticals (CRNX) United States $2.919B 0.00
NewAmsterdam Pharma (NAMS) Netherlands $2.709B 0.00
Hypermarcas (HYPMY) Brazil $2.686B 20.19
Procaps Group, S.A (PROCF) Luxembourg $2.557B 0.00
Catalyst Pharmaceuticals (CPRX) United States $2.520B 8.44
Centessa Pharmaceuticals (CNTA) United Kingdom $2.248B 0.00
Ocular Therapeutix (OCUL) United States $2.124B 0.00
Dyne Therapeutics (DYN) United States $1.919B 0.00
BioCryst Pharmaceuticals (BCRX) United States $1.744B 0.00
Guardian Pharmacy Services (GRDN) United States $1.673B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $1.578B 23.51
Ardelyx (ARDX) United States $1.533B 0.00
Harrow (HROW) United States $1.443B 0.00
Avadel Pharmaceuticals (AVDL) Ireland $1.433B 0.00
Xeris Biopharma Holdings (XERS) United States $1.264B 0.00
Evotec AG (EVO) Germany $1.243B 0.00
Collegium Pharmaceutical (COLL) United States $1.222B 6.68
Enliven Therapeutics (ELVN) United States $1.201B 0.00
ARS Pharmaceuticals (SPRY) United States $1.148B 0.00
Cronos Group (CRON) Canada $0.996B 0.00
Amylyx Pharmaceuticals (AMLX) United States $0.836B 0.00
Akebia Therapeutics (AKBA) United States $0.833B 0.00
Elite Pharmaceuticals (ELTP) United States $0.735B 0.00
Theravance Biopharma (TBPH) United States $0.699B 57.83
Rigel Pharmaceuticals (RIGL) United States $0.697B 7.18
ProKidney (PROK) United States $0.695B 0.00
KalVista Pharmaceuticals (KALV) United States $0.678B 0.00
Organogenesis (ORGO) United States $0.653B 0.00
Relay Therapeutics (RLAY) United States $0.619B 0.00
Bioventus (BVS) United States $0.612B 14.80
Tourmaline Bio (TRML) United States $0.601B 0.00
Siga Technologies (SIGA) United States $0.601B 7.42
USANA Health Sciences (USNA) United States $0.583B 11.95
Xencor (XNCR) United States $0.580B 0.00
Nektar Therapeutics (NKTR) United States $0.568B 0.00
Savara (SVRA) United States $0.567B 0.00
Oruka Therapeutics (ORKA) United States $0.554B 0.00
Zevra Therapeutics (ZVRA) United States $0.509B 0.00
Esperion Therapeutics (ESPR) United States $0.448B 0.00
Nanobiotix S.A (NBTX) France $0.429B 0.00
Aquestive Therapeutics (AQST) United States $0.376B 0.00
Aldeyra Therapeutics (ALDX) United States $0.350B 0.00
Altimmune (ALT) United States $0.338B 0.00
Larimar Therapeutics (LRMR) United States $0.300B 0.00
Nature's Sunshine Products (NATR) United States $0.297B 19.37
4D Molecular Therapeutics (FDMT) United States $0.288B 0.00
Galectin Therapeutics (GALT) United States $0.274B 0.00
AleAnna (ANNA) United States $0.270B 0.00
Tonix Pharmaceuticals Holding (TNXP) United States $0.260B 0.00
Lexeo Therapeutics (LXEO) United States $0.259B 0.00
Korro Bio (KRRO) United States $0.217B 0.00
Ironwood Pharmaceuticals (IRWD) United States $0.214B 33.00
Lyell Immunopharma (LYEL) United States $0.213B 0.00
Aclaris Therapeutics (ACRS) United States $0.209B 0.00
Heron Therapeutics (HRTX) United States $0.207B 0.00
OmniAb (OABI) United States $0.196B 0.00
MediWound (MDWD) Israel $0.180B 0.00
Journey Medical (DERM) United States $0.176B 0.00
Innate Pharma SA (IPHYF) France $0.173B 0.00
China SXT Pharmaceuticals (SXTC) China $0.169B 0.00
MEI Pharma (MEIP) United States $0.160B 0.00
Achieve Life Sciences (ACHV) Canada $0.152B 0.00
Profound Medical (PROF) Canada $0.134B 0.00
Inhibikase Therapeutics (IKT) United States $0.134B 0.00
Avalo Therapeutics (AVTX) United States $0.122B 0.00
Protara Therapeutics (TARA) United States $0.120B 0.00
Avita Medical (RCEL) United States $0.116B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.115B 0.00
Cassava Sciences (SAVA) United States $0.110B 0.00
Surrozen (SRZN) United States $0.104B 0.00
Wellgistics Health (WGRX) United States $0.103B 0.00
Dominari Holdings (DOMH) United States $0.099B 0.00
Champions Oncology (CSBR) United States $0.094B 21.25
Cardiol Therapeutics (CRDL) Canada $0.090B 0.00
VAXART, INC (VXRT) United States $0.089B 0.00
BioNxt Solutions (BNXTF) Canada $0.083B 0.00
Assertio Holdings (ASRT) United States $0.080B 0.00
Arch Biopartners (ACHFF) Canada $0.080B 0.00
Pyxis Oncology (PYXS) United States $0.079B 0.00
Context Therapeutics (CNTX) United States $0.075B 0.00
PMV Pharmaceuticals (PMVP) United States $0.074B 0.00
Unicycive Therapeutics (UNCY) United States $0.074B 0.00
Nutriband (NTRB) United States $0.072B 0.00
Gain Therapeutics (GANX) United States $0.072B 0.00
Liminatus Pharma (LIMN) United States $0.071B 0.00
Prelude Therapeutics (PRLD) United States $0.068B 0.00
Vivani Medical (VANI) United States $0.068B 0.00
Metagenomi (MGX) United States $0.065B 0.00
Karyopharm Therapeutics (KPTI) United States $0.062B 0.00
DURECT (DRRX) United States $0.060B 0.00
Inotiv (NOTV) United States $0.058B 0.00
PolyPid (PYPD) Israel $0.053B 0.00
Verrica Pharmaceuticals (VRCA) United States $0.053B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.052B 31.73
Rafael Holdings (RFL) United States $0.052B 0.00
Jupiter Neurosciences (JUNS) United States $0.051B 0.00
Fractyl Health (GUTS) United States $0.049B 0.00
FibroGen (FGEN) United States $0.048B 0.00
NRx Pharmaceuticals (NRXP) United States $0.046B 0.00
Plus Therapeutics (PSTV) United States $0.045B 0.00
Tempest Therapeutics (TPST) United States $0.044B 0.00
Telomir Pharmaceuticals (TELO) United States $0.043B 0.00
Klotho Neurosciences (KLTO) United States $0.043B 0.00
Century Therapeutics (IPSC) United States $0.042B 0.00
Acrivon Therapeutics (ACRV) United States $0.042B 0.00
ElectroCore (ECOR) United States $0.040B 0.00
Relmada Therapeutics (RLMD) United States $0.037B 0.00
Mural Oncology (MURA) Ireland $0.036B 0.00
SCYNEXIS (SCYX) United States $0.035B 0.00
Vivos Therapeutics (VVOS) United States $0.033B 0.00
Reviva Pharmaceuticals Holdings (RVPH) United States $0.031B 0.00
Iterum Therapeutics (ITRM) Ireland $0.030B 0.00
CASI Pharmaceuticals (CASI) China $0.028B 0.00
Mangoceuticals (MGRX) United States $0.025B 0.00
Enlivex Therapeutics (ENLV) Israel $0.025B 0.00
Cosmos Health (COSM) United States $0.024B 0.00
Natural Alternatives (NAII) United States $0.023B 0.00
Citius Pharmaceuticals (CTXR) United States $0.023B 0.00
Scienture Holdings (SCNX) United States $0.020B 0.00
Incannex Healthcare (IXHL) Australia $0.019B 0.00
Mannatech (MTEX) United States $0.018B 0.00
Ainos (AIMD) United States $0.018B 0.00
BioLineRx (BLRX) Israel $0.016B 0.00
Lipocine (LPCN) United States $0.016B 0.00
ProPhase Labs (PRPH) United States $0.014B 0.00
TherapeuticsMD (TXMD) United States $0.013B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.012B 0.00
Lyra Therapeutics (LYRA) United States $0.012B 0.00
BioVie (BIVI) United States $0.011B 0.00
ESSA Pharma (EPIX) Canada $0.011B 0.00
Phio Pharmaceuticals (PHIO) United States $0.011B 0.00
Talphera (TLPH) United States $0.011B 0.00
Aptorum Group (APM) United Kingdom $0.011B 0.00
Ernexa Therapeutics (ERNA) United States $0.010B 0.00
Traws Pharma (TRAW) United States $0.010B 0.02
Kiora Pharmaceuticals (KPRX) United States $0.010B 0.00
Heatwurx (PCSA) United States $0.010B 0.00
CERo Therapeutics Holdings (CERO) United States $0.009B 0.00
Carisma Therapeutics (CARM) United States $0.009B 0.00
TNF Pharmaceuticals (TNFA) United States $0.009B 0.00
Addex Therapeutics (ADXN) Switzerland $0.008B 0.00
VYNE Therapeutics (VYNE) United States $0.008B 0.00
TransCode Therapeutics (RNAZ) United States $0.008B 0.00
Biomerica (BMRA) United States $0.008B 0.00
NLS Pharmaceutics (NLSP) Switzerland $0.008B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.007B 0.00
Indaptus Therapeutics (INDP) United States $0.007B 0.00
XTL Biopharmaceuticals (XTLB) Israel $0.007B 0.00
Nuvilex (PMCB) United States $0.006B 0.00
Vyome Holdings (HIND) United States $0.006B 0.00
60 Degrees Pharmaceuticals (SXTP) United States $0.006B 0.00
Aditxt (ADTX) United States $0.005B 0.00
Alaunos Therapeutics (TCRT) United States $0.005B 0.00
Clearmind Medicine (CMND) Canada $0.005B 0.00
InMed Pharmaceuticals (INM) Canada $0.004B 0.00
Xenetic Biosciences (XBIO) United States $0.004B 0.00
Quoin Pharmaceuticals (QNRX) United States $0.004B 0.00
XORTX Therapeutics (XRTX) Canada $0.004B 0.00
CDT Equity (CDT) United States $0.004B 0.00
Jaguar Animal Health (JAGX) United States $0.004B 0.00
Shuttle Pharmaceuticals Holdings (SHPH) United States $0.004B 0.00
Redhill Biopharma (RDHL) Israel $0.003B 0.00
Qualigen Therapeutics (QLGN) United States $0.003B 0.00
Salarius Pharmaceuticals (SLRX) United States $0.003B 0.00
PainReform (PRFX) Israel $0.003B 0.00
SHINECO (SISI) China $0.002B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.002B 0.00
Universe Pharmaceuticals INC (UPC) China $0.002B 0.00
SciSparc (SPRC) Israel $0.001B 0.00
Indivior (INDV) United States $0.000B 13.64
4D Pharma (LBPS) United Kingdom $0.000B 0.00
Minerva Neurosciences (NERV) United States $0.000B 1.59
Patheon (PTHN) Netherlands $0.000B 0.00
RVL Pharmaceuticals (RVLP) United States $0.000B 0.00
Silence Therapeutics (SLN) United Kingdom $0.000B 0.00